-- (Updates with the analyst's commentary.)
Morgan Stanley lowered its price target on Thermo Fisher Scientific (TMO) to $620 from $670 while maintaining its overweight rating.
"Investors were clearly looking for more from TMO this quarter, particularly on the topline," Morgan Stanley said in a Monday note.
Morgan Stanley said it expects "limited interest" in the company until the "back-half ramp" Thermo Fisher's forecast implies.
Thermo Fisher Scientific has an average rating of buy and mean price target of $623.91, according to analysts polled by FactSet.
(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)
Price: $468.11, Change: $-1.60, Percent Change: -0.34%